nafamostat has been researched along with Electrolytes in 5 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Electrolytes: Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nafamostat mesilate (NFM) is used as an anticoagulant during hemodialysis in patients who have had complications due to hemorrhages." | 8.02 | Possible Role of Electrolytes on the Formation of Precipitates during the Infusion of Nafamostat Mesilate in Hemodialysis. ( Nishi, K; Otagiri, M; Seo, H; Taguchi, K; Tsukigawa, K; Yamasaki, K, 2021) |
| " "In vivo" generation of neutrophil-activating factors by gut proteases may be a cause of multiorgan failure after hemorrhagic shock, and can be prevented with the serine protease inhibitor nafamostat mesilate (Futhan)." | 7.72 | Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock. ( Coimbra, R; Doucet, JJ; Hoyt, DB; Hugli, TE; Junger, WG; Loomis, WH; Paul L, W; Schmid-Schönbein, GW, 2004) |
| "Nafamostat mesilate (NFM) is used as an anticoagulant during hemodialysis in patients who have had complications due to hemorrhages." | 4.02 | Possible Role of Electrolytes on the Formation of Precipitates during the Infusion of Nafamostat Mesilate in Hemodialysis. ( Nishi, K; Otagiri, M; Seo, H; Taguchi, K; Tsukigawa, K; Yamasaki, K, 2021) |
| " "In vivo" generation of neutrophil-activating factors by gut proteases may be a cause of multiorgan failure after hemorrhagic shock, and can be prevented with the serine protease inhibitor nafamostat mesilate (Futhan)." | 3.72 | Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock. ( Coimbra, R; Doucet, JJ; Hoyt, DB; Hugli, TE; Junger, WG; Loomis, WH; Paul L, W; Schmid-Schönbein, GW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyaji, MJ | 1 |
| Ide, K | 1 |
| Takashima, K | 1 |
| Maeno, M | 1 |
| Krallman, KA | 1 |
| Lazear, D | 1 |
| Goldstein, SL | 1 |
| Yamasaki, K | 1 |
| Nishi, K | 1 |
| Tsukigawa, K | 1 |
| Taguchi, K | 1 |
| Otagiri, M | 1 |
| Seo, H | 1 |
| Kim, HD | 1 |
| Malinoski, DJ | 1 |
| Borazjani, B | 1 |
| Patel, MS | 1 |
| Chen, J | 1 |
| Slone, J | 1 |
| Nguyen, XM | 1 |
| Steward, E | 1 |
| Schmid-Schonbein, GW | 2 |
| Hoyt, DB | 2 |
| Doucet, JJ | 1 |
| Coimbra, R | 1 |
| Junger, WG | 1 |
| Paul L, W | 1 |
| Loomis, WH | 1 |
| Hugli, TE | 1 |
| Okamoto, T | 1 |
| Mizoguchi, S | 1 |
| Terasaki, H | 1 |
| Morioka, T | 1 |
5 other studies available for nafamostat and Electrolytes
| Article | Year |
|---|---|
Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy.
Topics: Acute Kidney Injury; Anticoagulants; Benzamidines; Child; Citrates; Citric Acid; Continuous Renal Re | 2022 |
Possible Role of Electrolytes on the Formation of Precipitates during the Infusion of Nafamostat Mesilate in Hemodialysis.
Topics: Anions; Anticoagulants; Benzamidines; Dialysis Solutions; Electrolytes; Guanidines; Hemorrhage; Huma | 2021 |
Inhibition of intraluminal pancreatic enzymes with nafamostat mesilate improves clinical outcomes after hemorrhagic shock in swine.
Topics: Analysis of Variance; Animals; Benzamidines; Disease Models, Animal; Drug Evaluation, Preclinical; D | 2010 |
Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock.
Topics: Animals; Benzamidines; Blood Transfusion; Electrolytes; Enema; Guanidines; Intestinal Mucosa; Intest | 2004 |
Safety of high-dose of nafamostat mesilate: toxicological study in beagles.
Topics: Aldosterone; Animals; Anticoagulants; Benzamidines; Dogs; Dose-Response Relationship, Drug; Electrol | 1994 |